Development of a Novel Statewide Learning Collaborative to Increase Lung Cancer Guideline Adherence and Improve Cancer Care Delivery

开发新型全州学习协作,以提高肺癌指南的遵守率并改善癌症护理服务

基本信息

  • 批准号:
    9763344
  • 负责人:
  • 金额:
    $ 16.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-15 至 2022-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary / Abstract Lung cancer is the leading cause of cancer-related mortality in the United States, accounting for 221,200 new cases and 158,040 deaths annually (more than colon, breast and prostate cancers combined). Despite the presence of well-developed guidelines for care, adherence to these recommendations is variable and often poor. To help hospitals achieve optimal adherence to guidelines, meaningful comparative data on adherence to measurable quality indicators in lung cancer care must first be gathered in order to identify areas for improvement. Once such preliminary adherence data are available, assessing specific barriers to evidence- based care will guide the development of interventions to address the barriers. Once the interventions are combined into a quality improvement tool, systematic testing of implementation in a range of hospitals will be needed to assess efficacy, feasibility, sustainability, and generalizability. This project proposes to use a learning collaborative model to assess barriers to guideline adherence in lung cancer care and identify solutions. The ultimate goal of the proposal is to improve guideline adherence and decrease unwanted variation in lung cancer care. Lessons learned through evaluation of hospital adaptation and implementation of interventions will lead to identification of common principles that can guide diverse types of hospitals in providing effective, guideline adherent lung cancer care. This work will lead to a generalizable model to assess cancer care quality, understand the underlying reasons for variability, improve adherence to national guidelines and disseminate evidence-based best practices. The candidate, Dr. Odell, is a board-certified general thoracic surgeon with both a clinical and research focus on the treatment of lung cancer. His clinical training and prior research experience measuring outcomes and assessing interventions to optimize lung cancer treatment and working within the Illinois Surgical Quality Improvement Collaborative (ISQIC) has uniquely prepared him for this proposal. Dr. Odell's career goal is to become an independently funded investigator who combines advanced quantitative and qualitative analytics with expertise in implementation and dissemination science to facilitate effective, evidence-based cancer care though hospital-based programs. To fulfill this goal, he will need specific additional training during this award period to gain expertise in 3 areas: (1) quantitative evaluation methodology, (2) qualitative research methods, and (3) implementation and dissemination science. The mentorship team, experienced collaborators, institutional environment and robust quality improvement infrastructure of ISQIC are ideally suited to these educational goals. Finally, the project serves as an ideal vehicle for my career development objectives and will afford Dr. Odell the opportunity to directly apply the skills and techniques learned in qualitative methods, quantitative improvement principles, and implementation science and will position him to perform ongoing, innovate, independent research in cancer care delivery.
项目摘要/摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David D. Odell其他文献

Ex-vivo lung perfusion: National trends and post-transplant outcomes
离体肺灌注:全国性趋势及移植后结局
  • DOI:
    10.1016/j.healun.2024.09.020
  • 发表时间:
    2025-02-01
  • 期刊:
  • 影响因子:
    6.000
  • 作者:
    Jonathan E. Williams;Sara L. Schaefer;Ryan C. Jacobs;David D. Odell;Kiran H. Lagisetty;Aaron M. Williams
  • 通讯作者:
    Aaron M. Williams
Pulmonary Artery Sling: A Rare Presentation With Tracheobronchial Malacia in an Adult
  • DOI:
    10.1378/chest.10290
  • 发表时间:
    2010-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    David D. Odell;Adnan Majid;Charles T. Bakhos;Sidharta P. Gangadharan;Armin Ernst
  • 通讯作者:
    Armin Ernst
Postoperative outcomes following lung resection performed at private equity–acquired hospitals
在私募股权收购的医院进行肺切除术后的结果
  • DOI:
    10.1016/j.jtcvs.2024.12.032
  • 发表时间:
    2025-06-01
  • 期刊:
  • 影响因子:
    4.400
  • 作者:
    Jonathan E. Williams;Sara L. Schaefer;Ryan C. Jacobs;Faelan Jacobson-Davies;Andrew M. Ibrahim;David D. Odell
  • 通讯作者:
    David D. Odell
PP01.17 Neoadjuvant Therapy Before Resection of Primary Pulmonary Lymphoepithelial Carcinoma
原发性肺淋巴上皮癌切除术前的新辅助治疗
  • DOI:
    10.1016/j.jtho.2024.05.263
  • 发表时间:
    2024-07-01
  • 期刊:
  • 影响因子:
    20.800
  • 作者:
    Erik Wu;Joseph Reznicek;Anjana V. Yeldandi;Jyoti D. Patel;David D. Odell
  • 通讯作者:
    David D. Odell
The Society of Thoracic Surgeons Looking to the Future Scholarship Program: A 15-Year Review
  • DOI:
    10.1016/j.athoracsur.2023.09.016
  • 发表时间:
    2024-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Dianela Perdomo;Rachel Pebworth;Jennifer S. Lawton;Ahmet Kilic;Rishindra M. Reddy;Elizabeth A. David;David D. Odell;Stephen C. Yang
  • 通讯作者:
    Stephen C. Yang

David D. Odell的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David D. Odell', 18)}}的其他基金

Development and Implementation of the REmote Telehealth User-Reported caNcer Surveillance (RETURNS) Program for Lung Cancer
肺癌远程医疗用户报告癌症监测 (RETURNS) 计划的开发和实施
  • 批准号:
    10802764
  • 财政年份:
    2023
  • 资助金额:
    $ 16.75万
  • 项目类别:
Development of a Novel Statewide Learning Collaborative to Increase Lung Cancer Guideline Adherence and Improve Cancer Care Delivery
开发新型全州学习协作,以提高肺癌指南的遵守率并改善癌症护理服务
  • 批准号:
    10221631
  • 财政年份:
    2017
  • 资助金额:
    $ 16.75万
  • 项目类别:
Development of a Novel Statewide Learning Collaborative to Increase Lung Cancer Guideline Adherence and Improve Cancer Care Delivery
开发新型全州学习协作,以提高肺癌指南的遵守率并改善癌症护理服务
  • 批准号:
    10017909
  • 财政年份:
    2017
  • 资助金额:
    $ 16.75万
  • 项目类别:
Full Project 2: Supporting High Risk African American Men in Research, Engagement & Decision Making (SHARED)
完整项目 2:支持高风险非裔美国男性进行研究和参与
  • 批准号:
    10082865
  • 财政年份:
    2015
  • 资助金额:
    $ 16.75万
  • 项目类别:
Full Project 2: Supporting High Risk African American Men in Research, Engagement & Decision Making (SHARED)
完整项目 2:支持高风险非裔美国男性进行研究和参与
  • 批准号:
    10266785
  • 财政年份:
    2015
  • 资助金额:
    $ 16.75万
  • 项目类别:

相似海外基金

Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 16.75万
  • 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
  • 批准号:
    10738120
  • 财政年份:
    2023
  • 资助金额:
    $ 16.75万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10526768
  • 财政年份:
    2022
  • 资助金额:
    $ 16.75万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10701072
  • 财政年份:
    2022
  • 资助金额:
    $ 16.75万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10679092
  • 财政年份:
    2021
  • 资助金额:
    $ 16.75万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10432133
  • 财政年份:
    2021
  • 资助金额:
    $ 16.75万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10327065
  • 财政年份:
    2021
  • 资助金额:
    $ 16.75万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10377366
  • 财政年份:
    2019
  • 资助金额:
    $ 16.75万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10574496
  • 财政年份:
    2019
  • 资助金额:
    $ 16.75万
  • 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
  • 批准号:
    9403567
  • 财政年份:
    2017
  • 资助金额:
    $ 16.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了